Levetiracetam Spirig HC 100 mg/ml Soluzione orale
Country: Switzerland
Language: Italian
Source: Swissmedic (Swiss Agency for Therapeutic Products)
Patient Information leaflet
(PIL)
01-01-1900
Summary of Product characteristics
(SPC)
01-01-1900
Active ingredient:
levetiracetamum
Available from:
Spirig HealthCare AG
ATC code:
N03AX14
INN (International Name):
levetiracetamum
Pharmaceutical form:
Soluzione orale
Composition:
levetiracetamum 100 mg, natrii citras dihydricus, acidum citricum, E 218 2.5 mg, glycerolum, acesulfamum kalicum, maltitolum liquidum 300 mg, aromatica (Himbeere) cum alcohol benzylicus 0.0016 mg et propylenglycolum, aqua purificata, ad solutionem pro 1 ml corresp. natrium 0.99 mg.
Class:
B
Therapeutic group:
Synthetika
Therapeutic area:
Antiepileptikum
Authorization status:
zugelassen
Authorization date:
1970-01-01
Patient Information leaflet
•
Ricerca
•
Cerca SAI
•
Nuove omologazioni
•
Testi modificati
•
Scaricare
•
Aiuto
•
Accedi
IT
DE
FR
EN
AIPS - RICERCA INDIVIDUALE
Piattaforma di notifica elettronica per la vigilanza (ElViS)
Nessun risultato
Read the complete document
Summary of Product characteristics
•
Ricerca
•
Cerca SAI
•
Nuove omologazioni
•
Testi modificati
•
Scaricare
•
Aiuto
•
Accedi
IT
DE
FR
EN
AIPS - RICERCA INDIVIDUALE
Piattaforma di notifica elettronica per la vigilanza (ElViS)
Nessun risultato
Read the complete document
